Medicinal Genomics

Going forward, the company will focus on its wholly owned subsidiary Medicinal Genomics Corporation, which conducts cannabis genetics research.

The SBIR Phase 1 award will go toward developing a test using immuno-PCR technology to detect toxins in medical marijuana. 

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Courtagen Life Sciences today said that it has acquired Medicinal Genomics, a Marblehead, Mass.-based firm that has sequenced the genome of Cannabis sativa and Cannabis indica.

By Julia Karow
This article, originally published Jan. 17, has been updated with additional information from Courtagen.

Genetic cancer researcher Constance Griffin has passed away from pancreatic cancer.

Paired Ends

Premium

Kevin McKernan has founded Medicinal Genomics and is also now serving as its CEO. Most recently, he was the head of R&D for Ion Torrent at Life Technologies.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.